Tenecteplase failed to outperform aspirin for vision recovery when administered within 4.5 hours of onset of acute central ...
MedPage Today on MSN
FDA OKs more eye drops that can replace reading glasses
Once-daily carbachol/brimonidine tartrate significantly improves aging-related vision loss ...
Opus Genetics launches gene therapy clinical trial for MERTK-related retinitis pigmentosa: Research Triangle Park, North Carolina Wednesday, January 28, 2026, 16:00 Hrs [IST] Opus ...
Myra Vision has treated the first patient in its ADAPT clinical study evaluating the Calibreye TGT Surgical System in ...
The trial will enrol up to 70 patients with refractory glaucoma and has a 12-month primary effectiveness endpoint.
The MarketWatch News Department was not involved in the creation of this content.-- Initial case conducted by Dr. David Godfrey at Glaucoma Associates of Texas -- The IDE study wi ...
Owner and Therapist, Neil Yust from Fyzical Therapy and Balance Centers shows us how vision can affect your balance and also ...
Myra Vision's Calibreye aqueous shunt for glaucoma patients is designed to provide adjustable and reversible outflow control.
FRIDAY, Jan. 23, 2026 (HealthDay News) — Brain tumors are abnormal growths of cells in or around the brain. They can be ...
Nanoscope Therapeutics has received Pioneering Regenerative Medical Product (Sakigake) and Orphan Drug designations for ...
PRC-Saltillo, a global leader in augmentative and alternative communication (AAC), is pleased to announce the acquisition of the Therapy Box® suite of apps: Predictable®, Scene & Heard Pro®, Colourful ...
Japan's Ministry of Health, Labor and Welfare (MHLW) grants MCO-010 Pioneering Regenerative Medical Product (Sakigake) and Orphan Drug designations, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results